Just in case some readers of your post are misled by other comments, the FDA approval that you refer to is, of course, for the Pivotal Study IDE - the one that BARDA has paid $15M USD to Polynovo for.
Just in case some readers of your post are misled by other...
-
- There are more pages in this discussion • 12,168 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.41 |
Change
0.060(2.55%) |
Mkt cap ! $1.664B | |||
| Open | High | Low | Value | Volume |
| $2.32 | $2.42 | $2.31 | $3.627M | 1.517M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 32237 | $2.40 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.41 | 9997 | 1 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| PNV (ASX) Chart |